Anti-tumor activity of Abl kinases has been linked to signaling by tumor suppressor EphB4 (20), p53-P21 signaling (16, 18, 35), and opposing the proto-oncogenic YAP1 transcription factor (34, 36). The gene discussed is TP53; the disease is neoplasm.